The Broad Institute of MIT and Harvard announced a $25 million collaboration with Intel Corporation to scale researchers’ ability to analyze massive amounts of genomic data from diverse sources worldwide.
Through a five-year collaboration, researchers and software engineers at the new Intel-Broad Center for Genomic Data Engineering will build, optimize, and widely share new tools and infrastructure that will help scientists integrate and process genomic data, according to a press release. The project aims to optimize best practices in hardware and software for genome analytics to make it possible to combine and use research data sets that reside on private, public, and hybrid clouds.
The project will enable researchers worldwide to run more data-intensive studies and generate robust results more quickly by accessing data that may have been unavailable to them before.
“The size of genomic datasets doubles about every eight months and, as it does, the challenge of acquiring, processing, storing, and analyzing this information increases as well,” Eric Banks, director of the Data Sciences and Data Engineering group at the Broad Institute, said in a statement. “Working with Intel, we plan to build out solutions that can work across different infrastructures to facilitate efficient processing of these growing data sets, and then make these tools openly available for researchers worldwide. Our work is a step toward building something analogous to a superhighway to connect disparate databases of genomic information for the advancement of research and precision medicine.”
Building upon an existing collaboration, the new effort will apply Intel’s data analytics and artificial intelligence capabilities with Broad’s work in genomic data generation, health research, and analysis tools toward the goal of building new resources that will promote biomedical discoveries, including those that advance precision medicine.
Under the five-year agreement, the Intel-Broad Center for Genomic Data Engineering will focus on three goals. One goal is to overcome the challenge of diverse genomic datasets by optimizing Broad’s Genome Analytics Toolkit (GATK) best practices hardware recommendations for genomic workloads for on-premise, public cloud, and hybrid cloud use cases. A second goal is to simplify and accelerate the execution of genome analytics by optimizing genomics software tools such as GATK, Cromwell, and GenomicsDB on industry standard Intel-based platforms.
Additionally, a third goal is to empower users such as healthcare providers, pharmaceutical companies and academic research organizations to collaborate by partnering on workflow execution models across complex and distributed datasets. “Achieving this goal will enable secure processing of data across organizations, which can stimulate research and discovery, drug discovery, clinical trial recruitment, and ultimately clinical decision-making across the entire research and discovery ecosystem,” the organization stated.
Get the latest information on Healthcare Analytics and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.